Louise Larkin1, Birgitta Nordgren2, Helen Purtill3, Charles Brand4, Alexander Fraser5, Norelee Kennedy6. 1. L. Larkin, MSc, Department of Clinical Therapies, Faculty of Education and Health Sciences, University of Limerick, Limerick, Ireland. Louise.Larkin@ul.ie. 2. B. Nordgren, PhD, Division of Physiotherapy, Department of Neurobiology, Care Sciences and Society, Karolinska Institutet, Stockholm, Sweden. 3. H. Purtill, PhD, Department of Mathematics and Statistics, University of Limerick. 4. C. Brand, MSc, Department of Clinical Therapies, Faculty of Education and Health Sciences, University of Limerick. 5. A. Fraser, MD, FRCPI, Department of Rheumatology, University Hospital, Limerick, Ireland. 6. N. Kennedy, PhD, Department of Clinical Therapies, Faculty of Education and Health Sciences, University of Limerick.
Abstract
BACKGROUND: Accurate measurement of physical activity and sedentary behavior is an important consideration for health care professionals. The activPAL activity monitor has not been validated against a criterion measure for people with rheumatoid arthritis (RA). OBJECTIVE: The objective of this study was to determine the criterion validity of the activPAL activity monitor for measuring step counts, transition counts, and time spent in sedentary, standing, and walking behaviors in people with RA. DESIGN: A laboratory-based criterion validation study was conducted. METHODS: Participants with a confirmed medical diagnosis of RA were recruited from 2 outpatient rheumatology clinics. The testing procedure consisted of standardized testing components and tasks related to activities of daily living. Participants wore an activPAL activity monitor and were video recorded throughout the testing procedure. Direct observation was used as the criterion measure. Data analysis consisted of validation analysis of the activPAL activity monitor data and the criterion measure data. RESULTS: Twenty-four people participated in the study. Data from 20 participants were included in the final analysis. The activPAL significantly underestimated step counts by 26% and transition counts by 36%. There was no significant difference between the activPAL activity monitor and the criterion measure for time spent in sedentary, standing or light activity, and walking behaviors. LIMITATIONS: Validation of activities of daily living in a laboratory environment is a limitation of this study. CONCLUSIONS: The activPAL activity monitor underestimated step and transition counts and, therefore, is not valid for measuring these outcomes in people with RA. Relative to direct observation, the activPAL activity monitor is valid for measuring time spent in sedentary, standing, and walking behaviors in people with RA.
BACKGROUND: Accurate measurement of physical activity and sedentary behavior is an important consideration for health care professionals. The activPAL activity monitor has not been validated against a criterion measure for people with rheumatoid arthritis (RA). OBJECTIVE: The objective of this study was to determine the criterion validity of the activPAL activity monitor for measuring step counts, transition counts, and time spent in sedentary, standing, and walking behaviors in people with RA. DESIGN: A laboratory-based criterion validation study was conducted. METHODS:Participants with a confirmed medical diagnosis of RA were recruited from 2 outpatient rheumatology clinics. The testing procedure consisted of standardized testing components and tasks related to activities of daily living. Participants wore an activPAL activity monitor and were video recorded throughout the testing procedure. Direct observation was used as the criterion measure. Data analysis consisted of validation analysis of the activPAL activity monitor data and the criterion measure data. RESULTS: Twenty-four people participated in the study. Data from 20 participants were included in the final analysis. The activPAL significantly underestimated step counts by 26% and transition counts by 36%. There was no significant difference between the activPAL activity monitor and the criterion measure for time spent in sedentary, standing or light activity, and walking behaviors. LIMITATIONS: Validation of activities of daily living in a laboratory environment is a limitation of this study. CONCLUSIONS: The activPAL activity monitor underestimated step and transition counts and, therefore, is not valid for measuring these outcomes in people with RA. Relative to direct observation, the activPAL activity monitor is valid for measuring time spent in sedentary, standing, and walking behaviors in people with RA.
Authors: Sean G McKenna; Alan Donnelly; Bente Appel Esbensen; Laura Comber; Wan Lin Ng; Aqeel Maqsoon Anjum; Alexander Fraser; Norelee M Kennedy Journal: Rheumatol Int Date: 2021-01-02 Impact factor: 2.631
Authors: Dori E Rosenberg; Mikael Anne Greenwood-Hickman; Jing Zhou; Andrea J Cook; Kayne D Mettert; Julie Cooper; David Arterburn; Beverly B Green; Callie Walsh-Bailey; Jacqueline Kerr; Neville Owen; David Dunstan; Jennifer B McClure Journal: Contemp Clin Trials Date: 2021-10-16 Impact factor: 2.226
Authors: Mikael Anne Greenwood-Hickman; Jing Zhou; Andrea Cook; Kayne D Mettert; Bev Green; Jennifer McClure; David Arterburn; Stefani Florez-Acevedo; Dori E Rosenberg Journal: Gerontol Geriatr Med Date: 2022-04-27
Authors: Dori E Rosenberg; Amy K Lee; Melissa Anderson; Anne Renz; Theresa E Matson; Jacqueline Kerr; David Arterburn; Jennifer B McClure Journal: JMIR Res Protoc Date: 2018-02-12
Authors: Ciara M O'Brien; Joan L Duda; George D Kitas; Jet J C S Veldhuijzen van Zanten; George S Metsios; Sally A M Fenton Journal: Rheumatol Int Date: 2020-05-29 Impact factor: 2.631
Authors: Ciara M O'Brien; Joan L Duda; George D Kitas; Jet J C S Veldhuijzen van Zanten; George S Metsios; Sally A M Fenton Journal: Mediterr J Rheumatol Date: 2019-06-29